ALPMF OTC
Astellas Pharma Inc.
1W: -4.1%
1M: -3.0%
3M: -1.6%
YTD: +9.1%
1Y: +29.5%
3Y: +12.3%
5Y: -2.9%
$14.37
-0.30 (-2.06%)
Weekly Expected Move ±11.1%
$11
$13
$14
$16
$18
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3.59T
+7.5% ▲
5Y CAGR: +9.6%
Total Liabilities
$1.75T
-4.3% ▼
5Y CAGR: +14.5%
Shareholders Equity
$1.84T
+21.8% ▲
5Y CAGR: +5.9%
Cash & Investments
$283.4B
+29.8% ▲
5Y CAGR: -3.1%
Total Debt
$569.5B
-31.5% ▼
5Y CAGR: +15.4%
Net Debt
$286.1B
-55.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $316.0B | $376.8B | $335.7B | $188.4B | $283.4B |
| Short-Term Investments | $21.3B | $19.8B | $28.8B | $29.9B | $0 |
| Cash & ST Investments | $337.3B | $396.6B | $364.5B | $218.3B | $283.4B |
| Net Receivables | $382.5B | $428.0B | $535.0B | $632.5B | $766.6B |
| Inventory | $153.1B | $174.4B | $248.7B | $297.3B | $333.1B |
| Other Current Assets | $50.5B | $51.0B | $46.5B | $53.2B | $47.8B |
| Total Current Assets | $923.4B | $1.05T | $1.19T | $1.20T | $1.43T |
| Property, Plant & Equip. | $269.0B | $286.5B | $293.7B | $328.9B | $360.7B |
| Goodwill & Intangibles | $926.5B | $890.9B | $1.87T | $1.54T | $1.45T |
| Long-Term Investments | $141.2B | $90.8B | $144.4B | $172.2B | $159.6B |
| Other Non-Current Assets | -$1M | $54.2B | $64.2B | $1M | $43.7B |
| Total Non-Current Assets | $1.41T | $1.41T | $2.37T | $2.14T | $2.16T |
| Total Assets | $2.33T | $2.46T | $3.57T | $3.34T | $3.59T |
| — Liabilities — | |||||
| Accounts Payable | $130.7B | $140.2B | $185.2B | $187.8B | $201.0B |
| Short-Term Debt | $140.0B | $75.0B | $472.3B | $266.5B | $247.5B |
| Deferred Revenue | -$157.7B | -$88.5B | $0 | $0 | $0 |
| Other Current Liabilities | $420.1B | $442.0B | $458.1B | $572.7B | $708.2B |
| Total Current Liabilities | $687.4B | $726.0B | $1.29T | $1.06T | $1.23T |
| Long-Term Debt | $676M | $50.0B | $447.7B | $564.9B | $322.0B |
| Other Non-Current Liab. | $45.7B | $51.3B | $96.4B | $194.4B | $197.7B |
| Total Non-Current Liabilities | $184.7B | $222.5B | $687.9B | $764.7B | $521.0B |
| Total Liabilities | $872.1B | $948.6B | $1.97T | $1.83T | $1.75T |
| — Equity — | |||||
| Common Stock | $103.0B | $103.0B | $103.0B | $103.0B | $103.6B |
| Retained Earnings | $944.3B | $908.2B | $809.4B | $740.9B | $908.5B |
| Accumulated OCI | $247.5B | $340.6B | $533.3B | $521.6B | $677.2B |
| Total Stockholders Equity | $1.46T | $1.51T | $1.60T | $1.51T | $1.84T |
| Total Liabilities & Equity | $2.33T | $2.46T | $3.57T | $3.34T | $3.59T |
| — Key Metrics — | |||||
| Total Debt | $212.7B | $200.0B | $1.01T | $831.4B | $569.5B |
| Net Debt | -$103.2B | -$176.8B | $670.0B | $643.1B | $286.1B |
| Total Investments | $162.5B | $110.6B | $173.2B | $202.2B | $159.6B |